Establishing that SRP19 is a genuine component of the parasite SRP and that its nuclear import can be pharmacologically disrupted linked an SRP subunit to a druggable trafficking step in the parasite.
Evidence SRP19-GFP transgenic parasite lines with co-localization microscopy and ivermectin inhibition in P. falciparum asexual blood stages
- The specific molecular activity of SRP19 within the complex was not assayed directly
- Whether ivermectin killing is mechanistically attributable to SRP19 import loss specifically, versus general PfSRP disruption, is not resolved
- The functional role of nucleo-cytoplasmic shuttling for a canonically cytoplasmic SRP subunit is not defined